You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resistance to anti-EGFR monoclonal antibodies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Shanghai (Anti-EGFR and PD-1 inhibitor arm)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anti-EGFR and PD-1 inhibitor arm
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 26, 2023

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Isolation of Human Recombinant Therapeutic Monoclonal

Recruiting
  • Pseudomonas Aeruginosa
  • Multi-antibiotic Resistance
  • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
  • Grenoble, France
    Chu Grenoble Alpes
May 6, 2022

Alzheimer Trial (Lecanemab)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Jun 22, 2023

NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)

Recruiting
  • NSCLC
  • EGFR Gene Mutation
  • neo-antigen vaccine
  • Nanjing, China
    The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
Oct 19, 2023

Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • (no location specified)
Sep 15, 2023

HLX07, nsqNSCLC, High EGFR Expression Trial in Shanghai (HLX07+carboplatin+pemetrexed, HLX07+docetaxel, HLX07)

Not yet recruiting
  • HLX07, nsqNSCLC, High EGFR Expression
  • Shanghai, China
    Shanghai Chest Hospital
Jul 5, 2022

Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

Not yet recruiting
  • Long COVID
  • +2 more
  • San Francisco, California
    UCSF/Zuckerberg San Francisco General Hospital
Jun 2, 2023

Advanced Solid Tumors Trial in Shanghai (HLX07+Gemcitabine+Cisplatin, HLX07+Paclitaxel+Carboplatin, HLX07+mFOLFOX6)

Active, not recruiting
  • Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
May 5, 2022

Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

Completed
  • Clostridium Infection
  • Collection of peripheral blood mononuclear cells
  • Paris, France
    Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

Recruiting
  • Immunocompromised Patients
  • Data collection
  • Paris, Ile De France, France
    Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Duarte, California
  • +14 more
Jan 27, 2023

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

Not yet recruiting
  • Allergic Rhinitis
  • Conjunctivitis
  • (no location specified)
Jun 20, 2022

Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)

Not yet recruiting
  • Alzheimer Disease
  • Anti-amyloid Monoclonal Antibodies (mAbs)
  • Standard of Care
  • Albany, Georgia
  • +7 more
Aug 13, 2023

BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma Trial in United States

Recruiting
  • BRAF V600E Negative
  • +12 more
  • Cetuximab
  • +3 more
  • Scottsdale, Arizona
  • +15 more
Aug 23, 2022

Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

Not yet recruiting
  • Nephrotic Syndrome
  • Genova, Italy
    IRCCS G. Gaslini
Jan 19, 2023

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )

Not yet recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 23, 2022

Solid Tumor Trial in Shanghai (HLX07)

Not yet recruiting
  • Solid Tumor
  • Shanghai, China
    Fudan University shanghai cancer center
May 3, 2022

CRC Trial (HLX07, HLX10, mFOLFOX6)

Not yet recruiting
  • CRC
  • (no location specified)
May 1, 2022

Nasopharyngeal Carcinoma Trial in Shanghai (cetuximab (CTX) or nimotuzumab (NTZ))

Completed
  • Nasopharyngeal Carcinoma
  • cetuximab (CTX) or nimotuzumab (NTZ)
  • Shanghai, China
    Xiaoshen Wang
Mar 23, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (HLX07)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Jun 15, 2022